MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
18.58
-0.28 (-1.48%)
At close: Jan 29, 2026, 4:00 PM EST
18.58
0.00 (0.00%)
After-hours: Jan 29, 2026, 4:00 PM EST
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $815.66 million as of January 29, 2026.
Market Cap
815.66M
Enterprise Value
597.11M
1-Year Change
n/a
Ranking
Category
Stock Price
18.58
Market Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $815.66M, an increase of 15.81%. That is a compound annual growth rate of 77.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 823.08M | 7.37% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 918.69M |
| Omeros | 898.31M |
| Janux Therapeutics | 885.98M |
| Geron | 880.93M |
| Arvinas | 874.73M |
| YD Bio | 855.09M |
| Valneva SE | 848.19M |
| Bright Minds Biosciences | 829.94M |